Dr. Chen brings more than 20 years of experience in cancer research and drug discovery and development across the United States, Japan and China, where he led multiple innovative oncology R&D projects, and served as translational, clinical core team member of the Phase 1/2 clinical trials; Dr. Chen served as principle scientist of Eisai Inc. USA at Greater Boston, and General Manager of Adlai Nortye USA at Boston as well as Vice President of Adlai Nortye Biopharma. He obtained his PhD degree at University of Tokyo Graduate School of Medicine, and received Postdoc training at Harvard University.
